NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer
出版年份 2015 全文链接
标题
NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer
作者
关键词
Breast cancer, Brain metastasis, PEGylated irinotecan, NKTR-102
出版物
BMC CANCER
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-10-14
DOI
10.1186/s12885-015-1672-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models
- (2014) Ute Hoch et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Novel Preclinical Method to Quantitatively Evaluate Early-Stage Metastatic Events at the Murine Blood-Brain Barrier
- (2014) C. E. Adkins et al. Cancer Prevention Research
- Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,®/Doxil®—A Cerebral Open Flow Microperfusion Pilot Study
- (2014) Thomas Birngruber et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors
- (2014) Charles O Noble et al. Nanomedicine
- Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
- (2014) Pieter J. Gaillard et al. PLoS One
- CNS Metastases in Breast Cancer: Old Challenge, New Frontiers
- (2013) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Why Clinical Modulation of Efflux Transport at the Human Blood–Brain Barrier Is Unlikely: The ITC Evidence-Based Position
- (2013) J C Kalvass et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Advances in therapy for melanoma brain metastases
- (2013) Jaclyn C. Flanigan et al. CLINICS IN DERMATOLOGY
- Treatment of breast cancer brain metastases
- (2013) Silvia Hofer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Innovative Therapeutic Strategies in the Treatment of Brain Metastases
- (2013) Maria Caffo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009
- (2013) Rebecca H. Johnson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer
- (2013) Ignace B. Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Passive Tumor Targeting of Renal-Clearable Luminescent Gold Nanoparticles: Long Tumor Retention and Fast Normal Tissue Clearance
- (2013) Jinbin Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study
- (2013) Ahmad Awada et al. LANCET ONCOLOGY
- Brain metastases in HER2-positive breast cancer
- (2013) Nancy U Lin LANCET ONCOLOGY
- Paclitaxel–Hyaluronic NanoConjugates Prolong Overall Survival in a Preclinical Brain Metastases of Breast Cancer Model
- (2013) Rajendar K. Mittapalli et al. MOLECULAR CANCER THERAPEUTICS
- Brain Metastases: Can We Do More?
- (2013) Francesco Tomasello et al. World Neurosurgery
- P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
- (2013) Chris E. Adkins et al. Frontiers in Pharmacology
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors
- (2012) G. S. Jameson et al. CLINICAL CANCER RESEARCH
- Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study
- (2012) Virginia Zabaleta et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model
- (2011) M. Verreault et al. JOURNAL OF CONTROLLED RELEASE
- Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
- (2011) Anna Niwińska et al. JOURNAL OF NEURO-ONCOLOGY
- Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts
- (2011) L. P. Serwer et al. NEURO-ONCOLOGY
- The accuracy of cancer mortality statistics based on death certificates in the United States
- (2010) Robert R. German et al. Cancer Epidemiology
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
- (2008) A Régina et al. BRITISH JOURNAL OF PHARMACOLOGY
- Brain metastases: current management and new developments
- (2008) Riccardo Soffietti et al. CURRENT OPINION IN ONCOLOGY
- Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats
- (2008) Tripta Bansal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now